Incidence of Platelet Dysfunction by Thromboelastography-Platelet Mapping in Children Supported with ECMO: A Pilot Retrospective Study
Bleeding complications are common and decrease the odds of survival in children supported with extracorporeal membrane oxygenation (ECMO). The primary objective of this pilot study was to determine the incidence and magnitude of platelet dysfunction according to thromboelastography (TEG(®))-platelet mapping (PM) testing.
Percutaneous Assist Devices in Acute Myocardial Infarction with Cardiogenic Shock: Review, Meta-Analysis
This aim of this paper was to assess the impact of percutaneous cardiac support in cardiogenic shock (CS) complicating acute myocardial infarction (AMI), treated with percutaneous coronary intervention.
Lung Transplantation for Cystic Fibrosis
Lung transplantation is a viable option for many patients with cystic fibrosis (CF) and end-stage lung disease.
Options for Temporary Mechanical Circulatory Support
This review will examine the different options for commonly used temporary MCS devices including intra-aortic balloon pumps (IABPs), veno-arterial-extracorporeal membrane oxygenation (VA-ECMO), TandemHeart(®) (CardiacAssist, Pittsburg, PA, USA) Impella(®) and BVS 5000(®) (both Abiomed Inc., Danvers, MA, USA), CentriMag(®) and Thoratec percutaneous ventricular assist device (pVAD)(®) (both Thoratec Corporation, Pleasanton, CA, USA).
Is Extracorporeal Membrane Oxygenator a New Weapon to Improve Prognosis in Patients With Profound Cardiogenic Shock Undergoing Primary Percutaneous Coronary Intervention
In this review, we describe and interpret the potential role of circulatory mechanical support by extracorporeal membrane oxygenator (ECMO) in the setting of acute myocardial infarction (AMI) complicated by profound cardiogenic shock (CS) for improving clinical outcomes.
Transcatheter Closure of Post-Myocardial Infarction Ventricular Defect: Where Are We
Since 1988, Transcatheter closure of post-myocardial infarction ventricular defect became an alternative treatment for anatomically suitable patients with high risk of surgical closure.
Review and Outcome of Prolonged Cardiopulmonary Resuscitation
The maximal duration of cardiopulmonary resuscitation (CPR) is unknown. We report a case of prolonged CPR. We have then reviewed all published cases with CPR duration equal to or more than 20 minutes. The objective was to determine the survival rate, the neurological outcome, and the characteristics of the survivors.
Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation
This study sought to investigate demographic, clinical, and procedural determinants of outcomes in patients treated with percutaneous veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) initiated in the cardiac catheterization laboratory with a portable system.
Advanced Mechanical Circulatory Support for Post-Cardiotomy Cardiogenic Shock: A 20-Year Outcome Analysis in a Non-Transplant Unit
Advanced mechanical circulatory support (AMCS) can be used to salvage carefully selected number of such patients. High costs and major complication rates have lead to centralization and limited funding for such devices in the UK. We have looked the outcomes of such devices in a non-transplant, intermediate-size adult cardiothoracic surgery unit.
Cytokine Reduction in the Setting of an ARDS-Associated Inflammatory Response with Multiple Organ Failure
A 45-year-old male was admitted to our hospital with a small bowel obstruction due to torsion and was immediately scheduled for surgical intervention. At anesthesia induction, the patient aspirated and subsequently developed a severe SIRS with ARDS and multiple organ failure requiring the use of ECMO, CRRT, antibiotics, and low dose steroids
TAVR Procedure While on ECMO: A Case Study (EP Video)
Brent Thye presents a case report on a patient that had a TAVR procedure while on ECMO (14:32 minutes).
Using Autologous Blood to improve outcomes in Otologic Procedures (EP Video)
This presentation by Dr. Mark Widick will introduce the use of fibrin foam in ear reconstruction and briefly introduce key concepts in chronic ear disease and surgical repair (23:42 minutes).